Cargando…

Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis

A certain number of patients with ulcerative colitis (UC) are refractory to anti-TNF-α antibodies; biomarkers are thus needed to predict treatment efficacy. This study aimed to evaluate whether serum biomarkers that were reported to be associated with UC or anti-TNF-α antibody could predict the resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinoshita, Naohiko, Kakimoto, Kazuki, Shimizu, Hikaru, Nishida, Koji, Numa, Keijiro, Kawasaki, Yuka, Tawa, Hideki, Nakazawa, Kei, Koshiba, Ryoji, Hirata, Yuki, Sakiyama, Naokuni, Koubayashi, Eiko, Takeuchi, Toshihisa, Miyazaki, Takako, Higuchi, Kazuhide, Nakamura, Shiro, Nishikawa, Hiroki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456517/ https://www.ncbi.nlm.nih.gov/pubmed/36078882 http://dx.doi.org/10.3390/jcm11174952

Ejemplares similares

Therapeutic Drug Monitoring of Golimumab for the Prediction of Long-Term Clinical Remission in Patients with Ulcerative Colitis
por: Tawa, Hideki, et al.
Publicado: (2022)

Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis
por: Nakata, Satoshi, et al.
Publicado: (2022)

Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition
por: Kawasaki, Yuka, et al.
Publicado: (2023)

Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis
por: Numa, Keijiro, et al.
Publicado: (2023)

Fr581 EVALUATION OF SEQUENTIAL CHANGES IN THE INTESTINAL FLORA OF PATIENTS TAKING LOW-DOSE ASPIRIN AND A PROTON-PUMP INHIBITOR
por: Hirata, Yuki, et al.
Publicado: (2021)

Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis
por: Tatsumi, Yoshihiro, et al.
Publicado: (2023)

The Differential Diagnosis of Colorectal Polyps Using Colon Capsule Endoscopy
por: Nakazawa, Kei, et al.
Publicado: (2021)

Augmented O-GlcNAcylation alleviates inflammation-mediated colon carcinogenesis via suppression of acute inflammation
por: Hirata, Yoshimasa, et al.
Publicado: (2018)

Autophagy deficiency exacerbates colitis through excessive oxidative stress and MAPK signaling pathway activation
por: Kubota, Minori, et al.
Publicado: (2019)

Endoscopic diagnosis of Whipple disease in a patient without gastrointestinal symptoms: A case report
por: Henmi, Yujiro, et al.
Publicado: (2021)

Enhancement of O-linked N-acetylglucosamine modification promotes metastasis in patients with colorectal cancer and concurrent type 2 diabetes mellitus
por: Naka, Yutaka, et al.
Publicado: (2020)

Inflammatory Bowel Disease and Sarcopenia: Its Mechanism and Clinical Importance
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

The Relationship between the SARC-F Score and the Controlling Nutritional Status Score in Gastrointestinal Diseases
por: Ikegami, Takako, et al.
Publicado: (2022)

Comparison of SARC-F Score among Gastrointestinal Diseases
por: Ushiro, Kosuke, et al.
Publicado: (2021)

Prognostic Impact of the SARC-F Score in Gastrointestinal Advanced Cancers
por: Matsui, Masahiro, et al.
Publicado: (2021)

The Relevance in the Neutrophil to Lymphocyte Ratio and the SARC-F Score in Gastrointestinal Diseases
por: Yamasaki, Eiki, et al.
Publicado: (2022)

Grip Strength in Patients with Gastrointestinal Diseases
por: Asaishi, Ken, et al.
Publicado: (2022)

Golimumab for Rheumatoid Arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)

Preventive effect of ecabet sodium on low-dose aspirin-induced small intestinal mucosal injury: a randomized, double-blind, pilot study
por: Ota, Kazuhiro, et al.
Publicado: (2019)

Golimumab in unresponsive ulcerative colitis
por: Lippert, Elisabeth, et al.
Publicado: (2014)

Golimumab for the treatment of ulcerative colitis
por: Löwenberg, Mark, et al.
Publicado: (2014)

Golimumab in the treatment of ulcerative colitis
por: Cunningham, Georgina, et al.
Publicado: (2019)

Golimumab for the treatment of ulcerative colitis
por: Flamant, Mathurin, et al.
Publicado: (2017)

Cytomegalovirus infection in ulcerative colitis assessed by quantitative polymerase chain reaction: risk factors and effects of immunosuppressants
por: Henmi, Yujiro, et al.
Publicado: (2018)

Massive Bleeding from a Small Intestinal Submucosal Tumor-like Arterial Malformation: An Unclassifiable Vascular Lesion Revealed by a Detailed Pathological Evaluation
por: Ota, Kazuhiro, et al.
Publicado: (2019)

Long-Term Efficacy and Safety of Golimumab for Ulcerative Colitis in a Pediatric Inflammatory Bowel Disease Center in Japan
por: Tokita, Kazuhide, et al.
Publicado: (2022)

Safety, efficacy, and maneuverability of a self-propelled capsule endoscope for observation of the human gastrointestinal tract
por: Ota, Kazuhiro, et al.
Publicado: (2021)

Safety and clinical efficacy of golimumab in the treatment of arthritides
por: Simsek, Ismail, et al.
Publicado: (2010)

SAT-LB87 Golimumab Induced Thyroiditis
por: Mai, Mo M, et al.
Publicado: (2020)

Two cases of Erythrodermic psoriasis treated with Golimumab
por: Kudsi, Mayssoun, et al.
Publicado: (2022)

Effect of egualen sodium hydrate on small-intestinal mucosal damage induced by low-dose aspirin: a prospective randomized clinical trial
por: Iguchi, Munetaka, et al.
Publicado: (2018)

Prognostic Impact of Ectopic Fat Deposition within Psoas Muscle in Stage IV Gastric Cancer Patients Undergoing Systemic Chemotherapy
por: Ikegami, Takako, et al.
Publicado: (2022)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
por: Rahman, Proton, et al.
Publicado: (2020)

RETRACTED ARTICLE: Novel Therapeutic Approach Using Drug-loaded Adipose-derived Stem Cells for Pancreatic Cancer
por: Aoki, Masahiko, et al.
Publicado: (2019)

Retraction Note: Novel Therapeutic Approach Using Drug-loaded Adipose-derived Stem Cells for Pancreatic Cancer
por: Aoki, Masahiko, et al.
Publicado: (2021)

Effectiveness and Safety of Golimumab in the Treatment of Ulcerative Colitis: 52-Week Results from Post-Marketing Surveillance in Japan
por: Nakamura, Shiro, et al.
Publicado: (2022)

Effectiveness of Golimumab in Clinical Management of Patients with Rheumatoid Arthritis
por: Shono, Eisuke
Publicado: (2013)

Golimumab: A Novel Anti-Tumor Necrosis Factor
por: Rossini, Maurizio, et al.
Publicado: (2013)

Erythrodermic Psoriasis Treated with Golimumab: A Case Report
por: Lee, Won-Ku, et al.
Publicado: (2015)

Ocular toxicity of intravitreal golimumab in a rabbit model
por: DURMAZ ENGİN, Ceren, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kvk8df41gepeidm3d7iacs3b72